SCHEMBL6160192

SCHEMBL6160192

CCOC1OC(=O)CC1NC(=O)CC(C(=O)O)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 17/20 0.33
CASP1 P29466 15/20 0.32
CASP7 P55210 13/20 0.32
CASP8 Q14790 13/20 0.32
CASP6 P55212 11/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6200874 0.79 CASP3 (0.35) CASP3CASP1CASP8
SCHEMBL6157558 0.74 KMT2A (0.48) CASP1
SCHEMBL5831766 0.72 KDM4E (0.35) CASP3CASP1CASP7CASP8CASP6
SCHEMBL29317498 0.69 SMN1; SMN2 (0.35) CASP3CASP1CASP8
SCHEMBL3469761 0.68 KMT2A (0.39) CASP3CASP1CASP8
SCHEMBL644947 0.68 KMT2A (0.39) CASP3CASP1CASP8
SCHEMBL1490171 0.68 KMT2A (0.39) CASP3CASP1CASP8
SCHEMBL5496674 0.68 CASP3 (0.50) CASP3CASP1CASP7CASP8CASP6
SCHEMBL5496679 0.68 CASP3 (0.50) CASP3CASP1CASP7CASP8CASP6
SCHEMBL5491311 0.68 CASP3 (0.50) CASP3CASP1CASP7CASP8CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1082127-B1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1BETA CONVERTING ENZYME WARNER LAMBERT CO (US) 2005-06-22 EP disclosed
EP-1082127-A4 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME WARNER LAMBERT CO (US) 2002-10-09 EP disclosed
EP-1082127-A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME WARNER-LAMBERT COMPANY (US) 2001-03-14 EP disclosed
WO-1999056765-A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME WARNER-LAMBERT COMPANY (US) 1999-11-11 WO disclosed